Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 447
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Edmonton, Seattle WA, Aurora CO, Palo Alto CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase2, Phase3, Recruiting
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
for
Propionic Acidemia
Location: Edmonton, Stanford CA, Los Angeles CA, Chicago IL,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT04159103
Phase1, Phase2, Recruiting
WeRoaM: Wearable Remote Monitoring in Heart Failure
for
Heart Failure
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 8 - 18
Code: NCT06969560
Recruiting
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
for
Achondroplasia
Location: Edmonton, Aurora CO, Madison WI, Torrance CA,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 3 - 10
Code: NCT06842355
Phase2, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Edmonton, Seattle WA, Vancouver WA, Portland OR,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Edmonton, Tacoma WA, Minneapolis MN, Stanford CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Edmonton, Phoenix AZ, Long Beach CA, San Diego CA,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase3, Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Edmonton, Mill Creek WA, Portland OR, Murray UT,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase2, Phase3, Recruiting
Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome
for
Cubital Tunnel Syndrome, Electrical Stimulation
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT05395715
Recruiting
Improving Health Outcomes With Kefir
for
Systemic Inflammatory Response, Diabetes Mellitus, Type 2,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 24 - 70
Code: NCT06695221
Recruiting
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program
for
Neonatal Abstinence Syndrome
Location: Edmonton
Sponsor: University of Alberta
Sex: Female
Age: 0+
Code: NCT05226624
Recruiting
International Severe Asthma Registry: Canadian Cohort